Top Growth Trends in the Gastric Volvulus Treatment Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gastric Volvulus Treatment Market?
The gastric volvulus treatment market is projected to grow, fueled by an increasing elderly population. This demographic, aged 65 and beyond, is often susceptible to various illnesses owing to aging and weakened immunity. Gastric volvulus typically affects those over 50 years old, thus an upsurge in the elderly demographic is likely to stimulate the market. For example, data from the Population Reference Bureau (PRB), a US-based nonprofit organization, in January 2024 predicted a rise in Americans aged 65 and older, from 58 million in 2022 to 82 million by 2050 (a 47% increase), and a rise in their percentage from 17% of the total population to 23%. Consequently, an expanding elderly population is a significant contributor to the gastric volvulus treatment market growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
#What Long-Term Growth Rate is Expected for theGastric Volvulus Treatment Market Between 2025 and 2034?
The market for gastric volvulus treatment has seen significant growth in the recent past. The market value is expected to increase from $27.36 billion in 2024 to $28.95 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. Several factors have contributed to this growth during the historic period, including advancements in surgical practices, enhanced diagnostic technologies, heightened awareness and education, an increase in minimally invasive procedures, and ongoing research and clinical studies.
Over the upcoming years, the market size for gastric volvulus treatment is predicted to experience robust growth. By 2029, the market is projected to reach $37.48 billion with a compound annual growth rate (CAGR) of 6.7%. This growth within the forecast period can be credited to factors such as regulatory shifts and approvals, advancements in surgical procedures, an increasing elderly population, tailored treatment plans, and the use of cutting-edge imaging techniques. Key trends anticipated during the forecast period encompass less invasive surgical techniques, raised awareness and early intervention, research into treatment methods, cooperative medical practices, and personalized treatment strategies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382
What Are the Key Market Innovations in theGastric Volvulus Treatment Market Over the Coming Years?
Being at the forefront in terms of advancements, product innovations are visibly shaping the gastric volvulus treatment market. Large-scale enterprises active in this marketplace are consistently developing and introducing novel products to maintain and strengthen their market standing. An illustrative example of this was seen in October 2023 when the US pharmaceutical giant, Pfizer Inc., announced the endorsement of VELSIPITY (etrasimod) by the U.S. Food and Drug Administration (FDA). The drug, a once-daily oral sphingosine-1-phosphate (S1P) receptor activator, is intended for those suffering from moderate to severe active ulcerative colitis (UC). The officially recommended dosage for VELSIPITY is 2 mg. The product offers adults combating moderate to severe UC the option of steroid-free remission through a once-daily pill backed by a positive benefit-risk profile. This FDA approval of VELSIPITY signals a significant milestone for UC patients needing innovative treatments for their chronic condition and are prepared to undertake advanced therapy.
Who Are the Top Companies Driving Innovation and Growth in theGastric Volvulus Treatment Market?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Which Key Market Segments Comprise the Gastric Volvulus Treatment Market and Drive Its Revenue Growth?
The gastric volvulus treatment market covered in this report is segmented –
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smpGlobal Gastric Volvulus Treatment Market, Global Gastric Volvulus Treatment Market Report, Global Gastric Volvulus Treatment Market Trends, Global Gastric Volvulus Treatment Market Size
Browse Through More Reports Similar to the Gobal Gastric Volvulus Treatment Maret 2025, By The Business Research Company:
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Conjugated Monoclonal Antibodies Global Market Report 2024
Anemia And Other Blood Disorder Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
